Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.3.2.3 (
glutathione synthetase
)
678
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Ethylene dichloride
(
EDC
) is metabolized by two competing pathways both of which consume glutathione (GSH).
EDC
undergoes oxidation to form chloroacetaldehyde (CAA) which is detoxified by GSH and also reacts directly with GSH to form 2-(s-chloroethyl)-GSH. A physiological pharmacokinetic model developed for
EDC
was extended to describe tissue GSH turnover and its depletion after
EDC
exposures. This GSH model was necessary to keep track of GSH concentrations with time, as
EDC
metabolism is affected by GSH status. Reactions of GSH with
EDC
and GSH with CAA were defined as second-order. Steady-state GSH formation was modeled as zero-order and GSH loss as first-order. GSH rebound effects after its depletion were controlled by a
GSH synthetase
reaction, which allowed time- and GSH concentration-dependent feedback for increased GSH resynthesis. The model was developed for liver GSH in the rat and was extrapolated to include the lung. Allometric scaling was used to extrapolate the model to other animal species. Experimental observations in the rat and mouse were consistent with model predictions.
...
PMID:Physiological model for tissue glutathione depletion and increased resynthesis after ethylene dichloride exposure. 336 6